{"transactions":[{"id":3007956,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T20:06:38.000Z","date":"2020-10-09","kind":"purchase","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities by the registrant's board of directors."}],"balance_after":27764,"source":{"system":"sec-edgar","filing":"0001104659-20-114502","document":"tm2032958-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465920114502/tm2032958-1_4.xml","form_type":"4"}},{"id":3077572,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T20:11:29.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2020."}],"balance_after":17764,"source":{"system":"sec-edgar","filing":"0001104659-20-085629","document":"tm2025176d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465920085629/tm2025176d8_4.xml","form_type":"4"}},{"id":3180338,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T20:07:54.000Z","date":"2020-04-03","kind":"purchase","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2020."}],"balance_after":16314,"source":{"system":"sec-edgar","filing":"0001104659-20-044158","document":"tm2015091d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465920044158/tm2015091d8_4.xml","form_type":"4"}},{"id":3269955,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T21:15:18.000Z","date":"2020-02-12","kind":"purchase","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14864,"source":{"system":"sec-edgar","filing":"0001104659-20-021768","document":"tm207834-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465920021768/tm207834-2_4.xml","form_type":"4"}},{"id":3297623,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-30T21:07:54.000Z","date":"2020-01-28","kind":"purchase","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2019."}],"balance_after":7864,"source":{"system":"sec-edgar","filing":"0001104659-20-008687","document":"tm206156d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465920008687/tm206156d6_4.xml","form_type":"4"}},{"id":3330880,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-26T21:08:18.000Z","date":"2019-12-23","kind":"purchase","acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2019 in the aggregate amount of $6,250."}],"balance_after":6414,"source":{"system":"sec-edgar","filing":"0001104659-19-076123","document":"tm1927375-7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465919076123/tm1927375-7_4.xml","form_type":"4"}},{"id":3464024,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-10T20:05:46.000Z","date":"2019-07-09","kind":"purchase","acquired":true,"shares":20832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first and second quarters of 2019 in the aggregate amount of $12,500."}],"balance_after":99252,"source":{"system":"sec-edgar","filing":"0001144204-19-034304","document":"tv524967_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420419034304/tv524967_4.xml","form_type":"4"}},{"id":3545293,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-30T21:01:07.000Z","date":"2019-04-29","kind":"purchase","acquired":true,"shares":15065,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78420,"source":{"system":"sec-edgar","filing":"0001144204-19-022456","document":"tv520223_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420419022456/tv520223_4.xml","form_type":"4"}},{"id":3683489,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-29T21:03:36.000Z","date":"2019-01-27","kind":"purchase","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2018 in the amount of $6,250."}],"balance_after":63355,"source":{"system":"sec-edgar","filing":"0001144204-19-003518","document":"tv511872_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420419003518/tv511872_4.xml","form_type":"4"}},{"id":3750042,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-28T21:39:13.000Z","date":"2018-11-27","kind":"purchase","acquired":true,"shares":6000,"price":0.75,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd Digital Health L.P., which may be deemed attributable to Mr. Kamer because Mr. Kamer is a Managing Partner of OurCrowd Digital Health L.P. Mr. Kamer disclaims beneficial ownership of the securities set forth herein except to the extent of his pecuniary interest therein."}],"balance_after":57105,"source":{"system":"sec-edgar","filing":"0001144204-18-062023","document":"tv508096_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418062023/tv508096_form4.xml","form_type":"4"}},{"id":3795794,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T20:58:11.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $6,250."}],"balance_after":51105,"source":{"system":"sec-edgar","filing":"0001144204-18-052746","document":"tv504214_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418052746/tv504214_form4.xml","form_type":"4"}},{"id":3869924,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-10T20:08:28.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":4292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2018 in the amount of $6,250."}],"balance_after":44817,"source":{"system":"sec-edgar","filing":"0001144204-18-037844","document":"tv498263_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418037844/tv498263_form4.xml","form_type":"4"}},{"id":3899549,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T20:05:39.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":25846,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40525,"source":{"system":"sec-edgar","filing":"0001144204-18-033539","document":"tv496159_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418033539/tv496159_4.xml","form_type":"4"}},{"id":3956970,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T20:07:19.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":4057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2018 in the amount of $6,250."}],"balance_after":14679,"source":{"system":"sec-edgar","filing":"0001144204-18-022374","document":"tv491862_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418022374/tv491862_4.xml","form_type":"4"}},{"id":4103955,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-08T21:10:13.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":3983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $6,250."}],"balance_after":10622,"source":{"system":"sec-edgar","filing":"0001144204-18-001295","document":"tv482692_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418001295/tv482692_4.xml","form_type":"4"}},{"id":4161787,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2017-11-15T21:05:21.000Z","date":"2017-11-13","kind":"other","acquired":false,"shares":892858,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Kamer because Mr. Kamer is a Managing Partner of OurCrowd. Mr. Kamer disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3.5,"exercise_date":"2017-07-10","expiration_date":"2022-01-09","underlying":"Common Stock","underlying_shares":892858},"source":{"system":"sec-edgar","filing":"0001144204-17-059417","document":"tv479692_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417059417/tv479692_form4.xml","form_type":"4"}},{"id":4161786,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-15T21:05:21.000Z","date":"2017-11-13","kind":"grant","acquired":true,"shares":496031,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Kamer because Mr. Kamer is a Managing Partner of OurCrowd. Mr. Kamer disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Kamer because Mr. Kamer is a Managing Partner of OurCrowd. Mr. Kamer disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Kamer because Mr. Kamer is a Managing Partner of OurCrowd. Mr. Kamer disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."}],"balance_after":1388889,"source":{"system":"sec-edgar","filing":"0001144204-17-059417","document":"tv479692_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417059417/tv479692_form4.xml","form_type":"4"}},{"id":4180538,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T20:07:59.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":3.367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $6,250."}],"balance_after":6639,"source":{"system":"sec-edgar","filing":"0001144204-17-054098","document":"tv477610_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417054098/tv477610_4.xml","form_type":"4"}},{"id":4258895,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-11T20:07:46.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":2703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $6,250."}],"balance_after":3272,"source":{"system":"sec-edgar","filing":"0001144204-17-036439","document":"v470579_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417036439/v470579_4.xml","form_type":"4"}},{"id":4351311,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":145994,"kind":"person","name":"Kamer Allen","position":1,"cik":"0001697484","reported_name":"Kamer Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T20:15:53.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $2,083.33."}],"balance_after":569,"source":{"system":"sec-edgar","filing":"0001144204-17-020709","document":"v464362_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417020709/v464362_4.xml","form_type":"4"}}]}